LB
Latus Bio, Inc.
United States · Biotech · Healthtech · AI
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $97M | 8VC — Role not disclosedBenjamin Franklin Technology Partners — Role not disclosedBioAdvance — Role not disclosedDCVC Bio — Role not disclosedGaingels — Role not disclosedHatch BioFund — Role not disclosedHelen's Pink Sky Foundation — Role not disclosedKorea Development Bank — Role not disclosedModi Ventures — Role not disclosed |